Samsara Bio Capital, LLC Amarin Corp Plcuk Transaction History

Samsara Bio Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $3.69 $28,249 - $92,250	-25,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $91,000 - $194,000	-25,000 Reduced 50.0%	25,000 $105,000
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $694,032 - $1.2 Million	-145,195 Reduced 74.38%	50,000 $346,000
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $780,780 - $4.2 Million	195,195 New	195,195 $781,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.